You just read:

Mitsubishi Tanabe Pharma Canada Announces That Company's Treatment for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plan in Quebec

News provided by

Mitsubishi Tanabe Pharma Canada, Inc.

Apr 29, 2020, 09:00 ET